Imaging of coronary atherosclerosis: Intravascular ultrasound

European Heart Journal

Volumn 31, Issue 20, 2010, Pages

  Garcia Garcia, Hector M ^a   Costa, Marco A ^b   Serruys, Patrick W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Atherosclerosis; Imaging; Intravascular ultrasound

Indexed keywords

AMLODIPINE; ATORVASTATIN; AVASIMIBE; DARAPLADIB; ENALAPRIL; FLUINDOSTATIN; GLIMEPIRIDE; LOSARTAN; NIFEDIPINE; PERINDOPRIL; PIOGLITAZONE; PLACEBO; PRAVASTATIN; RIMONABANT; ROSUVASTATIN; SIMVASTATIN; TORCETRAPIB;

ARTERIAL WALL THICKNESS; ARTERY CALCIFICATION; ARTERY CATHETER; ATHEROMA; CARDIAC GRAFT REJECTION; CLINICAL ASSESSMENT; CORONARY ARTERY ATHEROSCLEROSIS; CROSS-SECTIONAL STUDY; DIAGNOSTIC IMAGING; DISEASE COURSE; DISEASE SEVERITY; HEART VENTRICLE REMODELING; HUMAN; INTRAVASCULAR ULTRASOUND; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ACUTE CORONARY SYNDROME; CALCINOSIS; CORONARY ARTERY DISEASE; ENDOSONOGRAPHY; EQUIPMENT DESIGN; HEART CATHETERIZATION; HUMANS; ULTRASONOGRAPHY, INTERVENTIONAL; VENTRICULAR REMODELING;

EID: 77958127422     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehq280     Document Type: Review

References (101)

1. Roberts WC,Jones AA. Quantitation of coronary arterial narrowing at necropsy in sudden coronary death: analysis of 31 patients and comparison with 25 control subjects. Am J Cardiol 1979;44:39-45.
2. Escaned J, Baptista J, Di Mario C, Haase J, Ozaki Y, Linker DT, de Feyter PJ, Roelandt JR, Serruys PW. Significance of automated stenosis detection during quantitative angiography. Insights gained from intracoronary ultrasound imaging. Circulation 1996;94:966-972.
3. Sathyanarayana S, Carlier S, Li W, Thomas L. Characterisation ofatherosclerotic plaque by spectral similarity of radiofrequency intravascular ultrasound signals. Euro Intervention 2009;5:133-139.
4. Kawasaki M, Bouma BE, Bressner J, Houser SL, Nadkarni SK, MacNeill BD, Jang IK, Fujiwara H, Tearney GJ. Diagnostic accuracy of optical coherence tom-ography and integrated backscatter intravascular ultrasound images for tissue characterization of human coronary plaques. J Am Coll Cardiol 2006;48:81-88.
5. Schaar JA, De Korte CL, Mastik F, Strijder C, Pasterkamp G, Boersma E, Serruys PW, Van Der Steen AF. Characterizing vulnerable plaque features with intravascular elastography. Circulation 2003;108:2636-2641. (Pubitemid 37466804)
6. Lockwood GR, Ryan LK, Hunt JW, Foster FS. Measurement of the ultrasonic properties of vascular tissues and blood from 35-65 MHz. Ultrasound Med Biol 1991;17:653-666.
7. Bridal SL, Fornes P, Bruneval P, Berger G. Parametric (integrated backscatter attenuation) images constructed using backscattered radio frequency signals (25-56 MHz) from human aortae in vitro. Ultrasound Med Biol 1997;23: 215-229.
8. Gardner CM, Tan H, Hull EL, Lisauskas JB, Sum ST, Meese TM, Jiang C, Madden SP, Caplan JD, Burke AP, Virmani R, Goldstein J, Muller JE. Detection of lipid core coronary plaques in autopsy specimens with a novel catheter based near-infrared spectroscopy system. Am Coll Cardiol Img 2008;1:638-648.
9. Gardner CM, Tan H, Hull EL, Lisauskas JB, Sum ST, Meese TM, Jiang C, Madden SP, Caplan JD, Burke AP, Virmani R, Goldstein J, Muller JE. Detection of lipid core coronary plaques in autopsyspecimens with a novel catheter-based near-infrared spectroscopy system.JACC Cardiovasc Imaging 2008;1:638-648.
10. Waxman S, Dixon SR, L'Allier P, Moses JW, Petersen JL, Cutlip D, Tardif JC, Nesto RW, Muller JE, Hendricks MJ, Sum ST, Gardner CM, Goldstein JA, Stone GW, Krucoff MW. In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: initial results of the SPECTACL study. JACC Cardiovasc Imaging 2009;2:858-868.
11. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for ather-osclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-1275.
12. Garćia-Garćia HMMG, Lerman A, Vince DG, Margolis MP, van Es GA, Morel MA, Nair A, Virmani R, Burke AP, Stone GW, Serruys PW. Tissue charac-terisation using intravascular radiofrequency data analysis: recommendations for acquisition, analysis, interpretation and reporting. Eurointervention 2009;5:177.
13. Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, Pinto FJ, Rosenfield K, Siegel RJ, Tuzcu EM, Yock PG. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measure-ment and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2001;37:1478-1492.
14. Di Mario C, The SH, Madretsma S, van Suylen RJ, Wilson RA, Bom N, Serruys PW, Gussenhoven EJ, Roelandt JR. Detection and characterization of vascular lesions by intravascular ultrasound: an in vitro study correlated with his-tology. J Am Soc Echocardiogr 1992;5:135-146.
15. Prati F, Arbustini E, Labellarte A, Dal Bello B, Sommariva L, Mallus MT, Pagano A, Boccanelli A. Correlation between high frequency intravascular ultrasound and histomorphology in human coronary arteries. Heart 2001;85:567-570.
16. Bruining N, Verheye S, Knaapen M, Somers P, Roelandt JR, Regar E, Heller I, de Winter S, Ligthart J, Van Langenhove G, de Feijter PJ, Serruys PW, Hamers R. Three-dimensional and quantitative analysis of atherosclerotic plaque compo-sition by automated differential echogenicity. Catheter Cardiovasc Interv 2007; 70:968-978.
17. Nair A, Kuban BD, Tuzcu EM, Schoenhagen P, Nissen SE, Vince DG. Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 2002;106:2200-2206.
18. Nair A, Margolis MP, Kuban BD, Vince DG. Automated coronary plaque charac-terisation with intravascular ultrasound backscatter: ex vivo validation. Euro Intervention 2007;3:113-120.
19. Nasu K, Tsuchikane E, Katoh O, Vince DG, Virmani R, Surmely J-Fi, Murata A, Takeda Y, Ito T, Ehara M, Matsubara T, Terashima M, Suzuki T Accuracy of in vivo coronary plaque morphology assessment: a validation study of in vivo virtual histology compared with in vitro histopathology. J Am Coll Cardiol 2006; 47:2405-2412.
20. Nasu K, Tsuchikane E, Katoh O, Vince DG, Margolis PM, Virmani R, Surmely JF, Ehara M, Kinoshita Y, Fujita H, Kimura M, Asakura K, Asakura Y, Matsubara T, Terashima M, Suzuki T Impact of intramural thrombus in coronary arteries on the accuracy oftissue characterization by in vivo intravascular ultrasound radio-frequency data analysis. Am J Cardiol 2008;101:1079-1083.
21. Granada JF, Wallace-Bradley D, Win HK, Alviar CL, Builes A, Lev EI, Barrios R, Schulz DG, Raizner AE, Kaluza GL. In vivo plaque characterization using intravas-cular ultrasound-virtual histology in a porcine model of complex coronary lesions. Arterioscler Thromb Vasc Biol 2007;27:387-393.
22. Van Herck J, De Meyer G, Ennekens G, Van Herck P, Herman A, Vrints C. Vali-dation of in vivo plaque characterisation by virtual histology in a rabbit model of atherosclerosis. Euro Intervention 2009;5:149-156.
23. Thim T, Hagensen MK, Wallace-Bradley D, Granada JF, Kaluza GL, Drouet L, Paaske WP, Botker HE, Falk E. Unreliable assessment of necrotic core by VHTM IVUS in porcine coronary artery disease. Circ Cardiovasc Imaging 2010; 3:384-391.
24. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C,Jorgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W. Guidelines for percutaneous coronary interventions. The task force for percutaneous cor-onary interventions of the European society of cardiology. Eur Heart J 2005;26: 804-847.
25. Bruining N, de Winter S, Roelandt JR, Rodriguez-Granillo GA, Heller I, van Domburg RT, Hamers R, de Feijter PJ. Coronary calcium significantly affects quantitative analysis of coronary ultrasound: importance for atherosclerosis progression/regression studies. Coron Artery Dis 2009;20:409-414.
26. Nair AMP, Kuban BD, Vince DG. Automated coronary plaque characterization with intravascular ultrasound backscatter: ex vivo validation. Eurointervention 2007;3:113-130.
27. Nissen SE, Gurley JC, Grines CL, Booth DC, McClure R, Berk M, Fischer C, DeMaria AN. Intravascular ultrasound assessment of lumen size and wall mor-phology in normal subjects and patients with coronary artery disease. Circulation 1991;84:1087-1099.
28. Pasterkamp G, Schoneveld AH, van der Wal AC, Haudenschild CC, Clarijs RJ, Becker AE, Hillen B, Borst C. Relation of arterial geometry to luminal narrowing and histologic markers for plaque vulnerability: the remodeling paradox. J Am Coll Cardiol 1998;32:655-662.
29. Varnava AM, Mills PG, Davies MJ. Relationship between coronary artery remo-deling and plaque vulnerability. Circulation 2002;105:939-943.
30. Burke AP, Kolodgie FD, Farb A, Weber D, Virmani R. Morphological predictors of arterial remodeling in coronary atherosclerosis. Circulation 2002;105: 297-303. (Pubitemid 34106176)
31. Kotani J, Mintz GS, Castagna MT, Pinnow E, Berzingi CO, Bui AB, Pichard AD, Satler LF, Suddath WO, Waksman R, Laird JR Jr, Kent KM, Weissman NJ. Intra-vascular ultrasound analysis of infarct-related and non-infarct-related arteries in patients who presented with an acute myocardial infarction. Circulation 2003; 107:2889-2893.
32. Maehara A, Mintz GS, Bui AB, Walter OR, Castagna MT, Canos D, Pichard AD, Satler LF, Waksman R, Suddath WO, Laird JR Jr, Kent KM, Weissman NJ. Mor-phologic and angiographic features of coronary plaque rupture detected by intravascular ultrasound. J Am Coll Cardiol 2002;40:904-910.
33. von Birgelen C, Klinkhart W, Mintz GS, Papatheodorou A, Herrmann J, Baumgart D, Haude M, Wieneke H, Ge J, Erbel R. Plaque distribution and vas-cular remodeling of ruptured and nonruptured coronary plaques in the same vessel: an intravascular ultrasound study in vivo. J Am Coll Cardiol 2001;37: 1864-1870.
34. Jeremias A, Spies C, Herity NA, Pomerantsev E, Yock PG, Fitzgerald PJ, Yeung AC Coronary artery compliance and adaptive vessel remodelling in patients with stable and unstable coronary artery disease. Heart 2000;84: 314-319.
35. Nakamura M, Nishikawa H, Mukai S, Setsuda M, Nakajima K, Tamada H, Suzuki H, Ohnishi T, Kakuta Y, Nakano T, Yeung AC Impact of coronary artery remodeling on clinical presentation of coronary artery disease: an intra-vascular ultrasound study. J Am Coll Cardiol 2001;37:63-69.
36. Gyongyosi M, Yang P, Hassan A, Domanovits H, Laggner A, Weidinger F, Glogar D. Intravascular ultrasound predictors of major adverse cardiac events in patients with unstable angina. Clin Cardiol 2000;23:507-515.
37. Gyongyosi M, Yang P, Hassan A, Weidinger F, Domanovits H, Laggner A, Glogar D. Arterial remodelling of native human coronary arteries in patients with unstable angina pectoris: a prospective intravascular ultrasound study. Heart 1999;82:68-74.
38. Tauth J, Pinnow E, Sullebarger JT, Basta L, Gursoy S, Lindsay J Jr, Matar F. Pre-dictors of coronary arterial remodeling patterns in patients with myocardial ischemia. Am J Cardiol 1997;80:1352-1355.
39. Rodriguez-Granillo GA, Serruys PW, Garcia-Garcia HM, Aoki J, Valgimigli M, van Mieghem CA, McFadden E, de Jaegere PP, de Feyter P. Coronary artery remo-delling is related to plaque composition. Heart 2006;92:388-391.
40. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. JAm Coll Cardiol 2006;47(Suppl. 8):C13-C18.
41. Schaar JA, Muller JE, Falk E, Virmani R, Fuster V, Serruys PW, Colombo A, Stefanadis C, Ward Casscells S, Moreno PR, Maseri A, van der Steen AF. Termi-nology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece. Eur Heart J 2004;25:1077-1082.
42. Garcia-Garcia HM, Goedhart D, Schuurbiers JC, Kukreja N, Tanimoto S, Daemen J, Morel MA, Bressers M, van Es GA, Wentzel J, Gijsen F, van der Steen AF, Serruys PW. Virtual histology and remodeling index allow in vivo identification of allegedly high risk coronary plaques in patients with acute cor-onary syndromes: a three vessel intravascular ultrasound radiofrequency data analysis. Eurointervention 2006;2:338-344.
43. Hong MK, Mintz GS, Lee CW, Lee JW, Park JH, Park DW, Lee SW, Kim YH, Cheong SS, Kim JJ, Park SW, Park SJ. A three-vessel virtual histology intravascular ultrasound analysis of frequency and distribution of thin-cap fibroatheromas in patients with acute coronary syndrome or stable angina pectoris. Am J Cardiol 2008;101:568-572.
44. Fujii K, Mintz GS, Carlier SG, Costa JR Jr, Kimura M, Sano K, Tanaka K, Costa RA, Lui J, Stone GW, Moses JW, Leon MB. Intravascular ultrasound profile analysis of ruptured coronary plaques. Am J Cardiol 2006;98:429-435.
45. Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK, Farb A, Guerrero LJ, Hayase M, Kutys R, Narula J, Finn AV, Virmani R. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003;349: 2316-2325.
46. Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, Pinto FJ, Rosenfield K, Siegel RJ, Tuzcu EM, Yock PG, O'Rourke RA, Abrams J, Bates ER, Brodie BR, Douglas PS, Gregoratos G, Hlatky MA, Hochman JS, Kaul S, Tracy CM, Waters DD, Winters WL. American College of Cardiology Clinical Expert Consensus Document on Standards For Acquisition, Measure-ment and Reporting of Intravascular Ultrasound Studies (IVUS): a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents developed in collaboration with the European Society ofCardiology endorsed by the society of cardiac angiography and interventions. J Am Coll Cardiol 2001;37:1478-1492.
47. Jensen LO, Mintz GS, Carlier SG, Fujii K, Moussa I, Dangas G, Mehran R, Stone GW, Leon MB, Moses JW. Intravascular ultrasound assessment of fibrous cap remnants after coronary plaque rupture. Am Heart J 2006;152: 327-332.
48. Ge J, Chirillo F, Schwedtmann J, Gorge G, Haude M, Baumgart D, Shah V, von Birgelen C, Sack S, Boudoulas H, Erbel R. Screening of ruptured plaques in patients with coronary artery disease by intravascular ultrasound. Heart 1999; 81:621-627.
49. von Birgelen C, Klinkhart W, Mintz GS, Wieneke H, Baumgart D, Haude M, Bartel T, Sack S, Ge J, Erbel R. Size of emptied plaque cavity following spon-taneous rupture is related to coronary dimensions not to the degree of lumen narrowing. A study with intravascular ultrasound in vivo. Heart 2000; 84:483-488.
50. Fujii K, Kobayashi Y, Mintz GS, Takebayashi H, Dangas G, Moussa I, Mehran R, Lansky AJ, Kreps E, Collins M, Colombo A, Stone GW, Leon MB, Moses JW. Intravascular ultrasound assessment of ulcerated ruptured plaques: a compari-son of culprit and nonculprit lesions of patients with acute coronary syndromes and lesions in patients without acute coronary syndromes. Circulation 2003;108: 2473-2478.
51. Fujii K, Carlier SG, Mintz GS, Takebayashi H, Yasuda T, Costa RA, Moussa I, Dangas G, Mehran R, Lansky AJ, Kreps EM, Collins M, Stone GW, Moses JW, Leon MB. Intravascular ultrasound study of patterns of calcium in ruptured cor-onary plaques. Am J Cardiol 2005;96:352-357.
52. Rioufol G, Gilard M, Finet G, Ginon I, Boschat J, Andre-Fouet X. Evolution of spontaneous atherosclerotic plaque rupture with medical therapy: long-term follow-up with intravascular ultrasound. Circulation 2004;110:2875-2880.
53. Hong MK, Mintz GS, Lee CW, Suh IW, Hwang ES,Jeong YH, Park DW, Kim YH, Han KH, Cheong SS, Kim JJ, Park SW, Park SJ. Serial intravascular ultrasound evi-dence of both plaque stabilization and lesion progression in patients with rup-tured coronary plaques: effects of statin therapy on ruptured coronary plaque. Atherosclerosis 2007;191:107-114.
54. Kubo T, Imanishi T, Takarada S, Kuroi A, Ueno S, Yamano T, Tanimoto T, Matsuo Y, Masho T, Kitabata H, Tsuda K, Tomobuchi Y, Akasaka T Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol 2007;50:933-939.
55. Uretsky BF, Kormos RL, Zerbe TR, Lee A, Tokarczyk TR, Murali S, Reddy PS, Denys BG, Griffith BP, Hardesty RL et al. Cardiac events after heart transplan-tation: incidence and predictive value of coronary arteriography. J Heart Lung Transplant 1992;11:S45-S51.
56. Tuzcu EM, Kapadia SR, Sachar R, Ziada KM, Crowe TD, Feng J, Magyar WA, Hobbs RE, Starling RC, Young JB, McCarthy P, Nissen SE. Intravascular ultra-sound evidence of angiographically silent progression in coronary atherosclero-sis predicts long-term morbidity and mortality after cardiac transplantation. J Am Coll Cardiol 2005;45:1538-1542.
57. Eisen HJ, Tuzcu EM, Dorent R, Kobashigawa J, Mancini D, Valantine-von Kaeppler HA, Starling RC, Sorensen K, Hummel M, Lind JM, Abeywickrama KH, Bernhardt P. Everolimus forthe prevention of allograft rejec-tion and vasculopathy in cardiac-transplant recipients. N Engl J Med 2003;349: 847-858.
58. Schartl M, Bocksch W, Koschyk DH, Voelker W, Karsch KR, Kreuzer J, Hausmann D, Beckmann S, Gross M. Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease. Circulation 2001;104:387-392.
59. Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, Crowe T, Howard G, Cooper CJ, Brodie B, Grines CL, DeMaria AN. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. J Am Med Assoc 2004;291: 1071-1080. (Pubitemid 38541684)
60. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R,Joyal SV, Hill KA, Pfeffer MA, Skene AM. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004;350:1495-1504.
61. Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu EM. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. J Am Med Assoc 2006;295:1556-1565.
62. Tardif JC, Gregoire J, L'Allier PL, Ibrahim R, Lesperance J, Heinonen TM, Kouz S, Berry C, Basser R, Lavoie MA, Guertin MC, Rodes-Cabau J. Effects of reconsti-tuted high-density lipoprotein infusions on coronary atherosclerosis: a random-ized controlled trial. J Am Med Assoc 2007;297:1675-1682.
63. Nissen SE, Tardif JC, Nicholls SJ, Revkin JH, Shear CL, Duggan WT, Ruzyllo W, Bachinsky WB, Lasala GP, Tuzcu EM. Effect oftorcetrapib on the progression of coronary atherosclerosis. N Engl J Med 2007;356:1304-1316.
64. Nissen SE, Tuzcu EM, Brewer HB, Sipahi I, Nicholls SJ, Ganz P, Schoenhagen P, Waters DD, Pepine CJ, Crowe TD, Davidson MH, Deanfield JE, Wisniewski LM, Hanyok JJ, Kassalow LM. Effect of ACAT inhibition on the progression ofcoron-ary atherosclerosis. N Engl J Med 2006;354:1253-1263.
65. Nissen SE, Tuzcu EM, Libby P, Thompson PD, Ghali M, Garza D, Berman L, Shi H, Buebendorf E, Topol EJ. Effect ofantihypertensive agents on cardiovascu-lar events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. J Am Med Assoc 2004;292: 2217-2225.
66. Rodriguez-Granillo GA, Vos J, Bruining N, Garcia-Garcia HM, de Winter S, Ligthart JM, Deckers JW, Bertrand M, Simoons ML, Ferrari R, Fox KM, Remme W, De Feyter PJ. Long-term effect of perindopril on coronary athero-sclerosis progression (from the perindopril's prospective effect on coronary atherosclerosis by angiography and intravascular ultrasound evaluation [PER-SPECTIVE] study). Am J Cardiol 2007;100:159-163.
67. Gerstein HC, Ratner RE, Cannon CP, Serruys PW, Garcia-Garcia HM, van Es GA, Kolatkar NS, Kravitz BG, Miller DM, Huang C, Fitzgerald PJ, Nesto RW. Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: the assess-ment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial. Circulation 2010;121: 1176-1187.
68. Nissen SE, Nicholls SJ, Wolski K, Nesto R, Kupfer S, Perez A, Jure H, De Larochelliere R, Staniloae CS, Mavromatis K, Saw J, Hu B, Lincoff AM, Tuzcu EM. Comparison of pioglitazone vs glimepiride on progression of coron-ary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial. J Am Med Assoc 2008;299:1561-1573.
69. Nasu K, Tsuchikane E, Katoh O, Tanaka N, Kimura M, Ehara M, Kinoshita Y, Matsubara T, Matsuo H, Asakura K, Asakura Y, Terashima M, Takayama T, Honye J, Hirayama A, Saito S, Suzuki T Effect of fluvastatin on progression of coronary atherosclerotic plaque evaluated by virtual histology intravascular ultrasound.JACC Cardiovasc Interv 2009;2:689-696.
70. Hong MK, Park DW, Lee CW, Lee SW, Kim YH, Kang DH, Song JK, Kim JJ, Park SW, Park SJ. Effects of statin treatments on coronary plaques assessed by volumetric virtual histology intravascular ultrasound analysis.JACC Cardiovasc Interv 2009;2:679-688.
71. Serruys PW, Garcia-Garcia HM, Buszman P, Erne P, Verheye S, Aschermann M, Duckers H, Bleie O, Dudek D, Botker HE, von Birgelen C, D'Amico D, Hutchinson T, Zambanini A, Mastik F, van Es GA, van der Steen AF, Vince DG, Ganz P, Hamm CW, Wijns W, Zalewski A. Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coron-aryatherosclerotic plaque. Circulation 2008;118:1172-1182.
72. Manfrini O, Mont E, Leone O, Arbustini E, Eusebi V, Virmani R, Bugiardini R Sources of error and interpretation of plaque morphology by optical coherence tomography. Am J Cardiol 2006;98:156-159.
73. Sawada T, Shite J, Garcia-Garcia HM, Shinke T, Watanabe S, Otake H, Matsumoto D, Tanino Y, Ogasawara D, Kawamori H, Kato H, Miyoshi N, Yokoyama M, Serruys PW, Hirata K. Feasibility of combined use of intravascular ultrasound radiofrequency data analysis and optical coherence tomography for detecting thin-cap fibroatheroma. Eur Heart J 2008;29:1136-1146.
74. Gonzalo N, Garcia-Garcia HM, Regar E, Barlis P, Wentzel J, Onuma Y, Ligthart J, Serruys PW. In vivo assessment of high-risk coronary plaques at bifurcations with combined intravascular ultrasound and optical coherence tomography. JACC Cardiovasc Imaging 2009;2:473-482.
75. Rioufol G, Finet G, Ginon I, Andre-Fouet X, Rossi R, Vialle E, Desjoyaux E, Convert G, Huret JF, Tabib A. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation 2002;106:804-808. doi:10.1161/01.CIR.0000025609.13806.31
76. Hong MK, Mintz GS, Lee CW, Kim YH, Lee SW, Song JM, Han KH, Kang DH, Song JK, Kim JJ, Park SW, Park SJ. Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: a three-vessel intravascu-lar ultrasound study in 235 patients. Circulation 2004;110:928-933.
77. Tanaka A, Shimada K, Sano T, Namba M, Sakamoto T, Nishida Y, Kawarabayashi T, Fukuda D, Yoshikawa J. Multiple plaque rupture and C-reactive protein in acute myocardial infarction. J Am Coll Cardiol 2005;45:1594-1599.
78. Hong MK, Mintz GS, Lee CW, Lee BK, Yang TH, Kim YH, Song JM, Han KH, Kang DH, Cheong SS, Song JK, Kim JJ, Park SW, Park SJ. The site of plaque rupture in native coronary arteries: a three-vessel intravascular ultrasound analy-sis. J Am Coll Cardiol 2005;46:261-265.
79. Tyczynski P, Pregowski J, Mintz GS, Witkowski A, Kim SW, Waksman R, Satler L, Pichard A, Kalinczuk L, Maehara A, Weissman NJ. Intravascular ultrasound assessment of ruptured atherosclerotic plaques in left main coronary arteries. Am J Cardiol 2005;96:794-798.
80. Pregowski J, Tyczynski P, Mintz GS, Kim SW, Witkowski A, Waksman R, Pichard A, Satler L, Kent K, Kruk M, Bieganski S, Ohlmann P, Weissman NJ. Inci-dence and clinical correlates of ruptured plaques in saphenous vein grafts: an intravascular ultrasound study. J Am Coll Cardiol 2005;45:1974-1979.
81. Pregowski J, Tyczynski P, Mintz GS, Kim SW, Witkowski A, Satler L, Kruk M, Waksman R, Maehara A, Weissman NJ. Intravascular ultrasound assessment of the spatial distribution of ruptured coronary plaques in the left anterior des-cending coronary artery. Am Heart J 2006;151:898-901.
82. Rodriguez-Granillo GA, Garcia-Garcia HM, Valgimigli M, Vaina S, van Mieghem C, van Geuns RJ, van der Ent M, Regar E, de Jaegere P, van der Giessen W, de Feyter P, Serruys PW. Global characterization of coronary plaque rupture phenotype using three-vessel intravascular ultrasound radiofre-quency data analysis. Eur Heart J 2006;27:1921-1927.
83. Hong YJ, Jeong MH, Choi YH, Ma EH, Ko JS, Lee MG, Park KH, Sim DS, Yoon NS, Youn HJ, Kim KH, Park HW, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC. Differences in intravascular ultrasound findings in culprit lesions in infarct-related arteries between ST segment elevation myocardial infarction and non-ST segment elevation myocardial infarction. J Cardiol 2010;56:15-22.
84. Okazaki S, Yokoyama T, Miyauchi K, Shimada K, Kurata T, Sato H, Daida H. Early statin treatment in patientswith acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study. Circulation 2004;110:1061-1068.
85. Jensen LO, Thayssen P, Pedersen KE, Stender S, Haghfelt T Regression of cor-onary atherosclerosis by simvastatin: a serial intravascular ultrasound study. Cir-culation 2004;110:265-270.
86. Petronio AS, Amoroso G, Limbruno U, Papini B, De Carlo M, Micheli A, Ciabatti N, Mariani M. Simvastatin does not inhibit intimal hyperplasia and rest-enosis but promotes plaque regression in normocholesterolemic patients undergoing coronary stenting: a randomized study with intravascular ultrasound. Am Heart J 2005;149:520-526.
87. Nishioka H, Shimada K, Kataoka T, Hirose M, Asawa K, Hasegawa T, Yamashita H, Ehara S, Kamimori K, Sakamoto T, Kobayashi Y, Yoshimura T, Yoshiyama M, Takeuchi K, Yoshikawa J. Impact of HMG-CoA reductase inhibi-tors for non-treated coronary segments. Osaka City Med J 2004;50:61-68.
88. Tani S, Watanabe I, Anazawa T, Kawamata H, Tachibana E, Furukawa K, Sato Y, Nagao K, Kanmatsuse K, Kushiro T. Effect of pravastatin on malondialdehyde-modified low-density lipoprotein levels and coronary plaque regression as determined by three-dimensional intravascular ultrasound. Am J Cardiol 2005; 96:1089-1094.
89. Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif J-C, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu EM, for the ASTEROID Investigators. Effect ofvery high-intensity statin therapy on regression of coronary atherosclerosis: the ASTER-OID trial. JAm Med Assoc 2006;295:1556-1565.
90. Takashima H, Ozaki Y, Yasukawa T, Waseda K, Asai K, Wakita Y, Kuroda Y, Kosaka T, Kuhara Y, Ito T. Impact of lipid-lowering therapy with pitavastatin, a new HMG-CoA reductase inhibitor, on regression of coronary atherosclerotic plaque. Circ J 2007;71:1678-1684.
91. Takayama T, Hiro T, Yamagishi M, Daida H, Hirayama A, Saito S, Yamaguchi T, Matsuzaki M. Effect of rosuvastatin on coronary atheroma in stable coronary artery disease: multicenter coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS). Circ J 2009;73:2110-2117.
92. Hiro T, Kimura T, Morimoto T, Miyauchi K, Nakagawa Y, Yamagishi M, Ozaki Y, Kimura K, Saito S, Yamaguchi T, Daida H, Matsuzaki M. Effect of intensive statin therapy on regression ofcoronary atherosclerosis in patients with acute coron-ary syndrome: a multicenter randomized trial evaluated by volumetric intravas-cular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study). J Am Coll Cardiol 2009;54:293-302.
93. Tardif JC, Gregoire J, L'Allier PL, Anderson TJ, Bertrand O, Reeves F, Title LM, Alfonso F, Schampaert E, Hassan A, McLain R, Pressler ML, Ibrahim R, Lesperance J, Blue J, Heinonen T, Rodes-Cabau J. Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions. Circulation 2004;110:3372-3377.
94. Nissen SE, Tsunoda T, Tuzcu EM, Schoenhagen P, Cooper CJ, Yasin M, Eaton GM, Lauer MA, Sheldon WS, Grines CL, Halpern S, Crowe T, Blankenship JC, Kerensky R. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized con-trolled trial. J Am Med Assoc 2003;290:2292-2300.
95. Tardif JC, Gregoire J, L'Allier PL, Ibrahim R, Anderson TJ, Reeves F, Title LM, Schampaert E, LeMay M, Lesperance J, Scott R, Guertin MC, Brennan ML, Hazen SL, Bertrand OF. Effects of the antioxidant succinobucol (AGI-1067) on human atherosclerosis in a randomized clinical trial. Atherosclerosis 2008; 197:480-486.
96. Nissen SE, Nicholls SJ, Wolski K, Rodes-Cabau J, Cannon CP, Deanfield JE, Despres JP, Kastelein JJ, Steinhubl SR, Kapadia S, Yasin M, Ruzyllo W, Gaudin C, Job B, Hu B, Bhatt DL, Lincoff AM, Tuzcu EM. Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coron-ary artery disease: the STRADIVARIUS randomized controlled trial. J Am Med Assoc 2008;299:1547-1560.
97. Luscher TF, Pieper M, Tendera M, Vrolix M, Rutsch W, van den Branden F, Gil R, Bischoff KO, Haude M, Fischer D, Meinertz T, Munzel T A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study. Eur Heart J 2009;30:1590-1597.
98. Yokoyama M, Komiyama N, Courtney BK, Nakayama T, Namikawa S, Kuriyama N, Koizumi T, Nameki M, Fitzgerald PJ, Komuro I. Plasma low-density lipoprotein reduction and structural effects on coronary atherosclerotic plaques by atorvastatin as clinically assessed with intravascular ultrasound radio-frequency signal analysis: a randomized prospective study. Am Heart J 2005; 150:287.
99. Kawasaki M, Sano K, Okubo M, Yokoyama H, Ito Y, Murata I, Tsuchiya K, Minatoguchi S, Zhou X, Fujita H, Fujiwara H. Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound. J Am Coll Cardiol 2005;45:1946-1953.
100. Toi T, Taguchi I, Yoneda S, Kageyama M, Kikuchi A, Tokura M, Kanaya T, Abe S, Matsuda R, Kaneko N. Early effect of lipid-lowering therapy with pitavastatin on regression of coronary atherosclerotic plaque. Comparison with atorvastatin. Circ J 2009;73:1466-1472.
101. Miyagi M, Ishii H, Murakami R, Isobe S, Hayashi M, Amano T, Arai K, Ohashi T, Uetani T, Matsubara T, Murohara T. Impact of long-term statin treatment on coronary plaque composition at angiographically severe lesions: a nonrando-mized study of the history of long-term statin treatment before coronary angio-plasty. Clin Ther2009;31:64-73.